PISANI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 7.509
AS - Asia 4.166
EU - Europa 2.350
SA - Sud America 803
AF - Africa 91
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.930
Nazione #
US - Stati Uniti d'America 7.383
SG - Singapore 1.544
CN - Cina 1.224
IE - Irlanda 1.098
HK - Hong Kong 881
BR - Brasile 666
RU - Federazione Russa 497
IT - Italia 194
DE - Germania 132
VN - Vietnam 129
FI - Finlandia 106
IN - India 79
GB - Regno Unito 74
CA - Canada 55
AR - Argentina 51
MX - Messico 48
IQ - Iraq 42
JP - Giappone 38
BE - Belgio 37
SE - Svezia 34
AT - Austria 32
BD - Bangladesh 29
PL - Polonia 29
NL - Olanda 25
TR - Turchia 24
FR - Francia 23
ZA - Sudafrica 23
EC - Ecuador 21
ID - Indonesia 21
CO - Colombia 18
ES - Italia 18
KR - Corea 16
UZ - Uzbekistan 16
MU - Mauritius 14
PK - Pakistan 14
JO - Giordania 13
AZ - Azerbaigian 12
KE - Kenya 12
MA - Marocco 12
SA - Arabia Saudita 12
VE - Venezuela 12
UY - Uruguay 10
PH - Filippine 9
PY - Paraguay 9
UA - Ucraina 9
CL - Cile 8
EG - Egitto 7
IL - Israele 7
KG - Kirghizistan 7
LT - Lituania 7
DZ - Algeria 6
IR - Iran 6
MY - Malesia 6
PE - Perù 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
GR - Grecia 5
AM - Armenia 4
AU - Australia 4
DO - Repubblica Dominicana 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
RS - Serbia 4
TH - Thailandia 4
CZ - Repubblica Ceca 3
GT - Guatemala 3
JM - Giamaica 3
NI - Nicaragua 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AO - Angola 2
BO - Bolivia 2
GA - Gabon 2
HN - Honduras 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
ET - Etiopia 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
Totale 14.919
Città #
Chandler 1.531
Dublin 1.094
Hong Kong 880
Ashburn 774
Singapore 636
Dallas 583
Boardman 331
Beijing 311
Princeton 297
Lawrence 288
Wilmington 282
Los Angeles 198
Medford 178
Redondo Beach 135
Buffalo 107
The Dalles 104
Fairfield 101
Ann Arbor 90
Shanghai 86
Helsinki 79
Falls Church 66
Moscow 63
Seattle 61
Columbus 59
Ho Chi Minh City 59
Norwalk 58
Washington 56
Chicago 55
New York 55
Santa Clara 49
São Paulo 49
Munich 47
Woodbridge 47
Rome 38
Brussels 37
Tokyo 37
Guangzhou 33
Brooklyn 32
Hanoi 31
San Francisco 26
Nanjing 25
Rio de Janeiro 24
Turku 23
Warsaw 22
Atlanta 21
Belo Horizonte 21
Mexico City 21
Pune 21
Boston 20
Stockholm 20
Toronto 20
Changsha 19
Falkenstein 18
Johannesburg 17
Milan 17
Nuremberg 17
Denver 16
Phoenix 16
Shijiazhuang 16
Tashkent 16
Houston 15
Jakarta 14
Montreal 14
Seoul 14
Pavia 13
Poplar 13
Porto Alegre 13
Tianjin 13
Baghdad 12
Orem 12
San Jose 12
Shenyang 12
Amman 11
Ankara 11
Brasília 11
Chennai 11
Nairobi 11
Shenzhen 11
Vienna 11
Zhengzhou 11
Baku 10
Düsseldorf 10
Hangzhou 10
Montevideo 10
Amsterdam 9
Goiânia 9
London 9
Charlotte 8
Jinan 8
Nanchang 8
Bishkek 7
Council Bluffs 7
Harbin 7
Jacksonville 7
Napoli 7
Quito 7
Bologna 6
Campo Grande 6
Curitiba 6
Dongguan 6
Totale 9.835
Nome #
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology 97
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission 96
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 95
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 93
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia 91
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia 85
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 84
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 83
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 82
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 82
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 81
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms 79
Oxytocin Modifies the Excitability and the Action Potential Shape of the Hippocampal CA1 GABAergic Interneurons 78
Corticostriatal synaptic plasticity in PINK1 heterozygous mice: Effects of mitochondrial complex I inhibition 78
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 78
Acetylcholine-mediated modulation of striatal function 78
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? 77
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 76
A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum 76
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 75
Abnormal plasticity in dystonia: Disruption of synaptic homeostasis 75
Acanthocytosis as a predisposing factor non-ketotic hyperglycemia induced chorea-ballism 74
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 74
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 74
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease 71
Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons 71
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 68
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 67
Impaired dopamine- and adenosine-mediated signaling and plasticity in a novel rodent model for DYT25 dystonia 67
Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition 67
A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology 67
The neuroligins and the synaptic pathway in Autism Spectrum Disorder 66
Ischemic injury precipitates neuronal vulnerability in Parkinson's disease: Insights from PINK1 mouse model study and clinical retrospective data 66
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 65
A2a receptor dysregulation in dystonia dyt1 knock-out mice 65
Effects of two weeks of cerebellar theta burst stimulation in cervical dystonia patients 64
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 64
Machine Learning-based Voice Assessment for the Detection of Positive and Recovered COVID-19 Patients 64
Hypoxia-induced electrical changes in striatal neurons 63
Facemasks and face recognition: Potential impact on synaptic plasticity 63
Metabotropic glutamate receptors and neuronal toxicity 62
Dopaminergic involvement in a drummer with focal dystonia: A case study 62
Neuromodulatory functions exerted by oxytocin on different populations of hippocampal neurons in rodents 61
Is transcranial direct current stimulation (tDCS) effective for chronic low back pain? A systematic review and meta-analysis 61
Dystonia as a network disorder: A concept in evolution 61
Diagnostic and Prognostic Value of External Anal Sphincter EMG Patterns in Multiple System Atrophy 61
Expanding the phenotype of Brunner syndrome from childhood to adulthood: Description of the second pediatric patient and his mother 60
Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum 60
Models of dystonia: an update 60
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 60
Facemasks and face recognition: Potential impact on synaptic plasticity 60
Dystonia 59
PINK1 Heterozygous Mutations Induce Subtle Alterations in Dopamine-Dependent Synaptic Plasticity 58
Deep brain stimulation in Parkinson's disease patients: biochemical evidence 58
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 58
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum 58
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 58
Deep learning and machine learning-based voice analysis for the detection of COVID-19: A proposal and comparison of architectures 57
Neurotensin receptors inhibit mGluR I responses in nigral dopaminergic neurons via a process that undergoes functional desensitization by G-protein coupled receptor kinases 57
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 57
Synaptic transmission in the striatum: from plasticity to neurodegeneration 57
Does SARS-Cov-2 invade the brain? Translational lessons from animal models 57
Enhanced mu opioid receptor–dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia 57
Correction to: Demographic and clinical determinants of neck pain in idiopathic cervical dystonia (Journal of Neural Transmission, (2020), 127, 10, (1435-1439), 10.1007/s00702-020-02245-4) 57
Camillo Golgi’s contributions to the anatomic basis of sensitivity in tendons 57
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 56
Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies 56
Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia 56
Long-term treatment with rotigotine in drug-naïve PSP patients 56
The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum 56
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 56
Loss-of-function of GNAL dystonia gene impairs striatal dopamine receptors-mediated adenylyl cyclase/ cyclic AMP signaling pathway 55
Promising rodent models in Parkinson's disease 55
Optogenetic Activation of Striatopallidal Neurons Reveals Altered HCN Gating in DYT1 Dystonia 55
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice 55
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia 55
Hypoxia in striatal and cortical neurones: membrane potential and Ca2+ measurements 54
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 54
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 54
L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons 54
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 54
Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction 54
Biofluids profile of α-Klotho in patients with Parkinson's disease 54
Group 1 mGluR responses in distinct striatal interneuron subtypes 53
Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation 53
Compliance with levodopa-carbidopa intestinal gel in a selected population in central south Italy: Beyond sex, a possible gender effect 53
The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection 53
Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID-19 Lockdown 53
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study 53
Axial postural abnormalities and pain in Parkinson's disease 52
Chorea Associated with JAK2V617F-Positive Essential Thrombocythemia 52
Wearable electronics assess the effectiveness of transcranial direct current stimulation on balance and gait in Parkinson’s disease patients 52
Muscarinic IPSPs in rat striatal cholinergic interneurones 52
Hypoxic and hypoglycaemic changes of intracellular pH in cerebral cortical pyramidal neurones 52
Pisa syndrome in Parkinson disease: An observational multicenter Italian study 52
Felbamate inhibits dihydropyridine-sensitive calcium channels in central neurons 51
Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment 51
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 51
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum 51
On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons 51
Totale 6.366
Categoria #
all - tutte 95.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021337 0 0 0 0 0 7 4 258 6 7 31 24
2021/20221.152 21 5 9 11 32 47 42 100 91 18 162 614
2022/20233.617 367 170 63 396 289 461 4 264 1.417 27 93 66
2023/20241.440 151 227 84 101 158 445 66 70 10 63 34 31
2024/20254.121 101 360 100 172 147 247 230 194 1.007 211 512 840
2025/20264.286 531 578 1.045 726 1.046 360 0 0 0 0 0 0
Totale 15.311